Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.
Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.
复制标题
利培酮预处理可防止新生儿海马病变后运动活动升高。
DOI:
10.1038/sj.npp.1300791
复制
发表时间:
2006
期刊:
影响因子:
--
通讯作者:
McNamara,RobertK
中科院分区:
文献类型:
--
作者:
Richtand,NeilM;Taylor,Benjamin;Welge,JeffreyA;Ahlbrand,Rebecca;Ostrander,MichelleM;Burr,Jeffrey;Hayes,Scott;Coolen,LiqueM;Pritchard,LaurelM;Logue,Aaron;Herman,JamesP;McNamara,RobertK
Long-standing behavioral abnormalities emerge after puberty in rats following neonatal hippocampal lesion, providing a developmental model of abnormal rat behavior that may have predictive validity in identifying compounds effective in treating symptoms of schizophrenia. We sought to test the predictive validity of the neonatal hippocampal lesion model in identifying preventive treatment for first-episode psychosis. We determined the effect of risperidone, recently studied for prevention of first-episode psychosis, on the development of elevated locomotor activity following neonatal hippocampal lesions. Rat pups received hippocampal or sham lesions on postnatal day 7, followed by treatment with risperidone or vehicle from postnatal days 35 to 56. Locomotor activity in response to novelty, amphetamine, and nocturnal locomotion were determined on postnatal day 57. Low-dose risperidone (45 μg/kg) pretreatment prevented elevated locomotor activity in some, but not all, of the behavioral tasks following neonatal hippocampal lesions. In contrast, higher risperidone pretreatment was less effective in preventing elevated locomotor activity following neonatal hippocampal lesions. Because low risperidone dosages were also found to be effective in preventing first-episode psychosis in human studies, these data support the predictive validity of the hippocampal lesion model in identifying medications for prevention of first-episode psychosis. Additionally, these data support the use of low-dose risperidone in psychosis prevention, and suggest the possibility that higher risperidone doses could be less effective in this application.
登录
查看更多内容
DOI:
--
发表时间:
1981
期刊:
American journal of medical genetics
影响因子:
--
作者:
E. Murphy
通讯作者:
E. Murphy
影响因子:
5
作者:
FERENCZ, C;RUBIN, JD;DOWNING, JW
通讯作者:
DOWNING, JW
影响因子:
2.8
作者:
HOFFMAN, JIE;CHRISTIANSON, R
通讯作者:
CHRISTIANSON, R
DOI:
--
发表时间:
1961
期刊:
Acta geneticae medicae et gemellologiae
影响因子:
--
作者:
Maurice Campbell
通讯作者:
Maurice Campbell
影响因子:
9.8
作者:
M. Lamy;J. de Grouchy;O. Schweisguth
通讯作者:
O. Schweisguth